Norprexanil (Amlodipine Besilate, Perindopril Arginine)

Amlodipine besilate and perindopril arginine, the active ingredients in Norprexanil, are a calcium channel blocker and an ACE inhibitor presented as oral tablets for systemic use. They are prescribed to lower elevated blood pressure in adult patients with hypertension.

GNH USA supplies Norprexanil as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide. The company adheres to European Union quality standards and provides batch‑tested products for global distribution, ensuring consistent potency and safety.

Norprexanil combines a calcium‑channel blocker and an ACE inhibitor to treat hypertension and related cardiovascular conditions. - Hypertension: reduces systolic and diastolic blood pressure in patients with essential hypertension. - High blood pressure: improves blood pressure control when monotherapy is insufficient. - Cardiovascular risk reduction: contributes to lowering the risk of stroke and myocardial infarction in hypertensive patients.

Norprexanil may cause a range of adverse reactions, which are categorized by frequency.

Common Side Effects: - Headache: mild to moderate intensity, often transient. - Peripheral edema: swelling of ankles or feet. - Flushing: sensation of warmth and redness. - Dizziness: especially after standing. - Cough: dry, non‑productive. - Fatigue: general tiredness.

Serious or Rare Side Effects: - Angioedema: swelling of face, lips, tongue, potentially airway‑obstructing. - Severe hypotension: marked drop in blood pressure causing faintness. - Liver dysfunction: elevated transaminases or hepatitis. - Myocardial infarction: rare occurrence of heart attack. - Renal impairment: worsening kidney function. - Neutropenia: low white‑blood‑cell count.

Before initiating Norprexanil, several precautionary measures should be considered. - Blood pressure monitoring: check baseline and periodic readings. - Renal function assessment: evaluate serum creatinine and eGFR. - Hepatic impairment: use with caution in patients with liver disease. - Known hypersensitivity: avoid if patient has reacted to amlodipine, perindopril, or any component. - Pregnancy and lactation: safety not established; use only if clearly needed. - Store at room temperature: keep in the original container, protect from moisture and direct sunlight.

Norprexanil can interact with other medicines, influencing its efficacy or safety.

Major Interactions (Avoid): - Concomitant ACE inhibitors or ARBs: risk of additive hypotension and renal dysfunction. - Aliskiren in diabetic patients: may cause severe hypotension and hyperkalemia. - Strong CYP3A4 inhibitors (e.g., ketoconazole): increase amlodipine plasma levels. - Potassium‑sparing diuretics: elevate risk of hyperkalaemia. - NSAIDs (high dose): may blunt antihypertensive effect.

Moderate Interactions (Monitor Closely): - Thiazide diuretics: may enhance blood‑pressure lowering. - Beta‑blockers: additive effect on heart rate and blood pressure. - Lithium: increased lithium levels, monitor serum concentration. - Rifampin: may reduce amlodipine concentrations. - Grapefruit juice: can raise amlodipine exposure.